Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
6,400
Employees6,400
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
6,400
Employees6,400

VRTX Key Statistics

Market cap
133.24B
Market cap133.24B
Price-Earnings ratio
33.49
Price-Earnings ratio33.49
Dividend yield
—
Dividend yield—
Average volume
1.18M
Average volume1.18M
High today
$531.37
High today$531.37
Low today
$522.72
Low today$522.72
Open price
$529.94
Open price$529.94
Volume
249.04K
Volume249.04K
52 Week high
$568.67
52 Week high$568.67
52 Week low
$412.27
52 Week low$412.27

Stock Snapshot

As of today, Vertex Pharmaceuticals(VRTX) shares are valued at $525.51. The company's market cap stands at 133.24B, with a P/E ratio of 33.49.

As of 2026-11-20, Vertex Pharmaceuticals(VRTX) stock has fluctuated between $522.72 and $531.37. The current price stands at $525.51, placing the stock +0.5% above today's low and -1.1% off the high.

The Vertex Pharmaceuticals(VRTX)'s current trading volume is 249.04K, compared to an average daily volume of 1.18M.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $412.27 at its lowest and $568.67 at its peak.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $412.27 at its lowest and $568.67 at its peak.

VRTX News

TipRanks 4h
Vertex Buy Rating Reiterated as Povetacicept Shows IgA Nephropathy Potential; $641 Price Target Unchanged

Analyst Ananda Ghosh from H.C. Wainwright maintained a Buy rating on Vertex Pharmaceuticals and keeping the price target at $641.00. Ananda Ghosh gave his Buy...

TipRanks 23h
Vertex Tests At-Home Injector Experience in IgA Nephropathy Study

Vertex Pharmaceuticals Inc. (VRTX) announced an update on their ongoing clinical study. Study Overview: Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is s...

Simply Wall St 2d
Is Vertex Pharmaceuticals Undervalued Following The FDA Decision On Povetacicept?

Vertex Pharmaceuticals (VRTX) steps into the spotlight as investors watch for the FDA's November 30 decision on kidney drug povetacicept, a potential catalyst f...

Is Vertex Pharmaceuticals Undervalued Following The FDA Decision On Povetacicept?

Analyst ratings

76%

of 33 ratings
Buy
75.8%
Hold
21.2%
Sell
3%

More VRTX News

The Motley Fool 3d
Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?

Healthcare investors often choose between established stability and high-growth innovation. Determining whether Johnson & Johnson (JNJ -1.36%) or Vertex Pharmac...

Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?
Simply Wall St 6d
The Bet Vertex Pharmaceuticals Holders Made

If you only glanced at the headlines on Vertex Pharmaceuticals over the past year, the story might have looked muddled. Revenue pushed ahead while net margin in...

The Bet Vertex Pharmaceuticals Holders Made

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.